Listed by the USPTO as WANG, CHANG YU
Tech Center 1600 • Art Units: 1643 1649 1658 1675
This examiner grants 33% of resolved cases
WANG, CHANG YU examines applications in Tech Center 1600 and Art Unit 1643. The record includes 878 resolved cases, a 33.4% allowance rate, and a median of 1423 days to allowance. The allowance rate indicates that fewer than half of the resolved matters reached allowance, and the median timing reflects a prosecution path extending well beyond three years.
The interview lift of 53.7% is a strong positive association between interviews and allowance. The leading companies are University of Florida Research Foundation Inc., Novartis AG, and Othair Prothena Limited. The leading firms are Casimir Jones, S.C., Knobbe, Martens, Olson & Bear, LLP, and LEYDIG VOIT & MAYER, LTD. Applicants may want to prioritize interviews, detailed technical explanations, and staged amendments in managing this profile.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18530028 | GLYCOPEPTIDES AND USES THEREOF | Non-Final OA | Arizona Board of Regents on Behalf of the University of Arizona |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy33.4% of resolved applications examined by Chang Yu Wang were allowed (878 resolved cases), compared with 41.5% across Art Unit 1643 over the last five years.
This examiner's interview lift is +53.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Chang Yu Wang took 1,423 days on average from filing to allowance.
Chang Yu Wang examines applications in Art Unit 1643 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
